The beat-and-raise quarter with margin expansion and a $1.0B buyback authorization is a strong bullish signal. Traders should watch for continued execution on organic growth (4.2% organic revenue growth) and further margin expansion as the company benefits from operating leverage and its LaunchPad cost initiatives.
LH drugs
LH drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 30 $315.53entry
- T+1 · 4mo ago −2.01%α −2.71% · $309.20
- T+5 · 3mo ago +0.32%α −3.31% · $316.53
- T+20 · 3mo ago +6.66%α +2.69% · $336.54
- T+60 · 25d ago +4.25%α +1.79% · $328.95
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Labcorp reported Q2 2026 revenue of $3.73B (up 5.8% YoY) and adjusted EPS of $4.99, beating consensus of $4.77 by 4.6%. The company raised full-year 2026 adjusted EPS guidance to $18.10-$18.55 (up $0.30 at midpoint) and increased its share repurchase authorization by $1.0B to $1.4B. Strong operating margin expansion (adjusted operating margin +70bps to 15.8%) and double-digit adjusted EPS growth (+14.9% YoY) drove the beat, with both Diagnostics and Biopharma segments contributing to the upside.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $3.73B vs $3.53B YoY, up 5.8%
- Adjusted EPS $4.99 vs consensus $4.77, a 4.6% beat
- Raised full-year 2026 adjusted EPS guidance to $18.10-$18.55 (up $0.30 at midpoint)
- Raised full-year revenue growth guidance to 5.4%-6.3% (up 30bps at midpoint)
- Adjusted operating margin expanded 70bps to 15.8%
- Board approved $1.0B increase in share repurchase authorization, bringing total to $1.4B
- Repurchased $353.8M of stock and paid down $500M in senior notes during Q2
- Diagnostics segment revenue +5.5% YoY, Biopharma segment revenue +6.5% YoY
Financial Impact
Q2 revenue $3.73B, adjusted EPS $4.99, raised FY guidance midpoint by $0.30 to $18.10-$18.55
Risk Factors
- Execution risk on integrating recent acquisitions ($225.7M in Q2)
- Potential impact from foreign exchange headwinds (0.4% on enterprise revenue guidance)
- Competitive pressures in the laboratory services market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000920148-26-000162 |
| Document: lh-20260730.htm | 0000920148-26-000162 |
| Document: 0000920148-26-000162-index-headers.html | 0000920148-26-000162 |
| Document: 0000920148-26-000162-index.html | 0000920148-26-000162 |
| Document: 0000920148-26-000162.txt | 0000920148-26-000162 |
| 8-K Data (Synthetic) | 0000920148-26-000162 |
Track record
29 reports on LH
4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers